Compare Repligen Corporation Common Stock (RGEN) vs Southern Copper Corp (SCCO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Repligen Corporation Common Stock vs Southern Copper Corp — how do they compare? Repligen Corporation Common Stock trades at $178.15 (market cap $11.14B), while Southern Copper Corp trades at $198.05 (market cap $175.13B). The key difference: Southern Copper Corp is far larger — about 15.7× Repligen Corporation Common Stock's market cap, and Southern Copper Corp pays a 2.12% dividend while Repligen Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Repligen Corporation Common Stock for 0 Days and Southern Copper Corp for 62 Days on average.
| RGEN | SCCO | |
|---|---|---|
Market Cap | $11.14B | $175.13B |
Volume | 1,259,263 | 611,484 |
Sector | Health | Basic Materials |
52-Week High | $194.57 | $219.70 |
52-Week Low | $102.87 | $120.02 |
Typical Hold Time | 0 Days | 62 Days |
Enterprise Value | $11.02B | $176.43B |
Dividend Yield | — | 2.12% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Southern Copper (SCCO) trades at $200.68, down 3.84% on the day, but maintains strong fundamentals with impressive earnings beats and robust profitability metrics. The company shows consistent revenue growth from $10.0B in 2022 to $13.4B in 2025, with net income margins expanding to 35.87%. Technical indicators show a bullish trend with support at $204 and resistance at $210, while analyst sentiment remains divided with a consensus price target of $165.60.
SCCO presents a mixed investment case with exceptional profitability and growth prospects from its Mexican projects, but faces valuation concerns with a P/E of 31.12 and divided analyst ratings. Key risks include copper price volatility and execution challenges, while institutional interest remains active with recent purchases by Virginia Retirement Systems.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →About Southern Copper Corp
Southern Copper Corp is an integrated producer of copper and other minerals and operates the mining, smelting, and refining facilities in Peru and Mexico. Its production includes copper, molybdenum, zinc, and silver. The company operates through the following segments: Peruvian operations, Mexican open-pit operations, and Mexican underground mining operations. Southern Copper generates the majority of its revenue from the sale of copper and the rest from the sale of non-copper products, such as molybdenum, silver, zinc, lead, and gold. Its geographical segments are The Americas, Europe, and Asia.
Read more on SCCO →
